EMICIZUMAB PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A AND INHIBITORS: A SYSTEMATIC REVIEW

被引：0
|
作者：
Camelo, R. [1 ]
Prudente, T. P. [2 ]
Minare, D. V. [2 ]
Gomes, G. D. P. V. C. [2 ]
Roberti, M. D. R. F. [2 ]
机构：
[1] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil
[2] Univ Fed Goias, Fac Med, Goiania, Go, Brazil
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO061
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [1] Emicizumab prophylaxis in people with hemophilia A and inhibitors: a systematic review and meta-analysis
    Prudente, Tiago Paiva
    Camelo, Ricardo Mesquita
    Guimaraes, Rafael Alves
    Roberti, Maria do Rosario Ferraz
    [J]. SAO PAULO MEDICAL JOURNAL, 2024, 142 (05):
  • [2] Emicizumab Prophylaxis in Hemophilia A with Inhibitors
    Aledort, Louis M.
    Ewenstein, Bruce M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2193 - 2193
  • [3] Emicizumab Prophylaxis in Hemophilia A with Inhibitors
    Oldenburg, Johannes
    Mahlangu, Johnny N.
    Kim, Benjamin
    Schmitt, Christophe
    Callaghan, Michael U.
    Young, Guy
    Santagostino, Elena
    Kruse-Jarres, Rebecca
    Negrier, Claude
    Kessler, Craig
    Valente, Nancy
    Asikanius, Elina
    Levy, Gallia G.
    Windyga, Jerzy
    Shima, Midori
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09): : 809 - 818
  • [4] Emicizumab Prophylaxis in Hemophilia A with Inhibitors REPLY
    Oldenburg, Johannes
    Levy, Gallia G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2194 - 2195
  • [5] Efficacy/effectiveness and safety of emicizumab prophylaxis of people with hemophilia A: a systematic review and meta-analysis
    Muniz, Roberto Lucio
    Camelo, Ricardo Mesquita
    Araujo, Maiara Silva
    Barbosa, Mariana Michel
    Guerra, Augusto Afonso
    Acurcio, Francisco de Assis
    Alvares-Teodoro, Juliana
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (12) : 1087 - 1097
  • [6] Cost-Effectiveness of Emicizumab for Prophylaxis in People with Severe Hemophilia A without Inhibitors
    Decker-Palmer, Marquita
    Lin, Chia-Wei
    Wilson, Michele
    McDade, Cheryl
    Bawa, Komal
    Kowal, Stacey
    Ravelo, Arliene
    Yu, Elaine
    Ko, Richard H.
    [J]. BLOOD, 2022, 140 : 13041 - 13042
  • [7] ECONOMIC IMPACT OF EMICIZUMAB PROPHYLAXIS FOR HEMOPHILIA A WITH AND WITHOUT INHIBITORS
    Cortesi, P. A.
    Castaman, G.
    Mantovani, L. G.
    [J]. VALUE IN HEALTH, 2020, 23 : S699 - S699
  • [8] Emicizumab Prophylaxis in Patients with Hemophilia. with and without Inhibitors
    Ebbert, Patrick T.
    Xavier, Frederico
    Seaman, Craig D.
    Ragni, Margaret V.
    [J]. BLOOD, 2019, 134
  • [9] Emicizumab prophylaxis overcomes factor VIII inhibitors in Hemophilia A
    Shima, Midori
    [J]. JOURNAL OF PEDIATRICS, 2017, 190 : 289 - 289
  • [10] Management of Joint Replacement in Hemophilia a with Inhibitors during Emicizumab Prophylaxis
    Santagostino, Elena
    Mancuso, Maria Elisa
    Novembrino, Cristina
    Boscolo, Massimo Anzoletti
    Clerici, Marigrazia
    Pasta, Gianluigi
    Solimeno, Luigi Piero
    Peyvandi, Flora
    [J]. BLOOD, 2017, 130
12345